ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Mispro Becomes Gold Sponsor of LabCentral, Advancing Access to Vivarium Space for Early-Stage Biotech Companies

Mispro, a leader in contract vivarium facilities and services for preclinical drug development, is proud to announce its new Gold-level sponsorship of LabCentral, the premiere network of coworking lab space in Cambridge, MA. This sponsorship marks a significant expansion of the long-standing relationship between the two organizations, positioning Mispro as an integrated contract vivarium provider for LabCentral’s resident companies.

LabCentral, which provides fully permitted laboratory and office space to emerging biotech startups, has been a launchpad for over 300 companies since its founding in 2013. By partnering with Mispro, LabCentral enhances its value proposition to resident companies, offering streamlined access to turnkey vivarium facilities and services that support preclinical drug development.

For startups and early-stage biotech companies, the combined resources of LabCentral and Mispro offer a significant advantage. The ability to access dedicated vivarium space alongside lab and office facilities ensures hands-on control of preclinical research, accelerates timelines, and eliminates the cost and complexity of outsourcing. Moreover, the collaborative environment provided by LabCentral fosters connections, mentorship, and shared expertise, amplifying the value of the resources available.

Dr. Johannes Fruehauf, MD, PhD, CEO and Co-founder of LabCentral, added:

“Our expanded relationship with Mispro provides seamless access to high-quality vivarium space, services, and expertise, which are invaluable to LabCentral’s resident startups. This integrated vivarium offering is easily accessible, cost-effective, and adaptable to our residents’ evolving needs, enabling them to focus on accelerating their innovations.”

Yohan Tessier, President and COO of Mispro, added:

“Sponsoring LabCentral underscores Mispro’s commitment to supporting biotech startups and fostering innovation in the heart of Kendall Square. As an integrated contract vivarium provider for LabCentral, we’re proud to play a critical role in ensuring resident companies have seamless access to the preclinical infrastructure they need to advance their discoveries.”

ABOUT MISPRO

Mispro is a leading contract vivarium organization providing biomedical researchers with turnkey, full-service vivarium facilities to conduct preclinical in vivo studies. With locations in metro Boston/Cambridge, New York, Raleigh-Durham (RTP), Philadelphia, South San Francisco, Palo Alto, San Carlos, and Montreal, Mispro supports innovation by offering a flexible, cost-effective alternative to outsourcing early-stage studies or internalizing an in-house vivarium. For more information, visit www.mispro.com.

ABOUT LABCENTRAL

A private, non-profit institution, LabCentral is a launchpad for high potential life-sciences and biotech startups with 243,000 square feet of space across Kendall Square in Cambridge, Mass., and the Harvard University campus. Founded in 2013, LabCentral offers a full complement of programming and networking to life sciences entrepreneurs in addition to fully permitted laboratory and office space for early-stage and growing life sciences companies. More information is available at www.labcentral.org.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.